World Stroke Organization Brain & hEart globAl iniTiative Program
© 2023 S. Karger AG, Basel..
INTRODUCTION: The World Stroke Organization (WSO) Brain & Heart Task Force developed the Brain & hEart globAl iniTiative (BEAT), a pilot feasibility implementation program to establish clinical collaborations between cardiologists and stroke physicians who work at large healthcare facilities.
METHODS: The WSO BEAT pilot project focused on atrial fibrillation (AF) and patent foramen ovale (PFO) detection and management, and poststroke cardiovascular complications known as the stroke-heart syndrome. The program included 10 sites from 8 countries: Brazil, China, Egypt, Germany, Japan, Mexico, Romania, and the USA The primary composite feasibility outcome was the achievement of the following 3 implementation metrics (1) developing site-specific clinical pathways for the diagnosis and management of AF, PFO, and the stroke-heart syndrome; (2) establishing regular Neurocardiology rounds (e.g., monthly); and (3) incorporating a cardiologist to the stroke team. The secondary objectives were (1) to identify implementation challenges to guide a larger program and (2) to describe qualitative improvements.
RESULTS: The WSO BEAT pilot feasibility program achieved the prespecified primary composite outcome in 9 of 10 (90%) sites. The most common challenges were the limited access to specific medications (e.g., direct oral anticoagulants) and diagnostic (e.g., prolonged cardiac monitoring) or therapeutic (e.g., PFO closure devices) technologies. The most relevant qualitative improvement was the achievement of a more homogeneous diagnostic and therapeutic approach.
CONCLUSION: The WSO BEAT pilot program suggests that developing neurocardiology collaborations is feasible. The long-term sustainability of the WSO BEAT program and its impact on quality of stroke care and clinical outcomes needs to be tested in a larger and longer duration program.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:53 |
|---|---|
| Enthalten in: |
Cerebrovascular diseases (Basel, Switzerland) - 53(2024), 1 vom: 03., Seite 115-124 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sposato, Luciano A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Atrial fibrillation |
|---|
| Anmerkungen: |
Date Completed 14.02.2024 Date Revised 25.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1159/000530471 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM35778801X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM35778801X | ||
| 003 | DE-627 | ||
| 005 | 20240326234825.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1159/000530471 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1348.xml |
| 035 | |a (DE-627)NLM35778801X | ||
| 035 | |a (NLM)37276846 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sposato, Luciano A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a World Stroke Organization Brain & hEart globAl iniTiative Program |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.02.2024 | ||
| 500 | |a Date Revised 25.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 S. Karger AG, Basel. | ||
| 520 | |a INTRODUCTION: The World Stroke Organization (WSO) Brain & Heart Task Force developed the Brain & hEart globAl iniTiative (BEAT), a pilot feasibility implementation program to establish clinical collaborations between cardiologists and stroke physicians who work at large healthcare facilities | ||
| 520 | |a METHODS: The WSO BEAT pilot project focused on atrial fibrillation (AF) and patent foramen ovale (PFO) detection and management, and poststroke cardiovascular complications known as the stroke-heart syndrome. The program included 10 sites from 8 countries: Brazil, China, Egypt, Germany, Japan, Mexico, Romania, and the USA The primary composite feasibility outcome was the achievement of the following 3 implementation metrics (1) developing site-specific clinical pathways for the diagnosis and management of AF, PFO, and the stroke-heart syndrome; (2) establishing regular Neurocardiology rounds (e.g., monthly); and (3) incorporating a cardiologist to the stroke team. The secondary objectives were (1) to identify implementation challenges to guide a larger program and (2) to describe qualitative improvements | ||
| 520 | |a RESULTS: The WSO BEAT pilot feasibility program achieved the prespecified primary composite outcome in 9 of 10 (90%) sites. The most common challenges were the limited access to specific medications (e.g., direct oral anticoagulants) and diagnostic (e.g., prolonged cardiac monitoring) or therapeutic (e.g., PFO closure devices) technologies. The most relevant qualitative improvement was the achievement of a more homogeneous diagnostic and therapeutic approach | ||
| 520 | |a CONCLUSION: The WSO BEAT pilot program suggests that developing neurocardiology collaborations is feasible. The long-term sustainability of the WSO BEAT program and its impact on quality of stroke care and clinical outcomes needs to be tested in a larger and longer duration program | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Atrial fibrillation | |
| 650 | 4 | |a Implementation | |
| 650 | 4 | |a Neurocardiology | |
| 650 | 4 | |a Patent foramen ovale | |
| 650 | 4 | |a Quality improvement | |
| 650 | 4 | |a Stroke | |
| 700 | 1 | |a Martins, Sheila |e verfasserin |4 aut | |
| 700 | 1 | |a Scheitz, Jan F |e verfasserin |4 aut | |
| 700 | 1 | |a Aspberg, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Gurol, M Edip |e verfasserin |4 aut | |
| 700 | 1 | |a Abdalla, Mohamed |e verfasserin |4 aut | |
| 700 | 1 | |a Arauz, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Cano-Nigenda, Vanessa |e verfasserin |4 aut | |
| 700 | 1 | |a Fiorilli, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Israel, Carsten |e verfasserin |4 aut | |
| 700 | 1 | |a Kusano, Kengo |e verfasserin |4 aut | |
| 700 | 1 | |a Mansour, Ossama |e verfasserin |4 aut | |
| 700 | 1 | |a Messé, Steven R |e verfasserin |4 aut | |
| 700 | 1 | |a Pille, Arthur |e verfasserin |4 aut | |
| 700 | 1 | |a Secchi, Thaís |e verfasserin |4 aut | |
| 700 | 1 | |a Polanczyk, Carisi A |e verfasserin |4 aut | |
| 700 | 1 | |a Biolo, Andreia |e verfasserin |4 aut | |
| 700 | 1 | |a Ramadan, Ismail |e verfasserin |4 aut | |
| 700 | 1 | |a Sallam, Ashraf |e verfasserin |4 aut | |
| 700 | 1 | |a Schäbitz, Wolf |e verfasserin |4 aut | |
| 700 | 1 | |a Toyoda, Kazunori |e verfasserin |4 aut | |
| 700 | 1 | |a Valencia, Sharon |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Shang |e verfasserin |4 aut | |
| 700 | 1 | |a Xiong, Yunyun |e verfasserin |4 aut | |
| 700 | 1 | |a Zaki, Amr |e verfasserin |4 aut | |
| 700 | 1 | |a Saposnik, Gustavo |e verfasserin |4 aut | |
| 700 | 1 | |a Fisher, Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Bahit, M Cecilia |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cerebrovascular diseases (Basel, Switzerland) |d 1997 |g 53(2024), 1 vom: 03., Seite 115-124 |w (DE-627)NLM090577663 |x 1421-9786 |7 nnns |
| 773 | 1 | 8 | |g volume:53 |g year:2024 |g number:1 |g day:03 |g pages:115-124 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1159/000530471 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 53 |j 2024 |e 1 |b 03 |h 115-124 | ||